India Nears Breakthrough as Single-Dose Dengue Vaccine Enters Final Trials – SUCH TV
As dengue cases surge worldwide, an Indian vaccine candidate has entered Phase III trials, raising hopes for one of the world’s first single-dose shots against the mosquito-borne disease. Final Phase Testing Underway Indian pharmaceutical firm Panacea Biotec has begun final-stage trials of its dengue vaccine candidate, DengiAll, after nearly 15 years of development. More than…